Candriam Equities L Biotechnology Class C Fonds
188,23
EUR
-0,87
EUR
-0,46
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 6,91% |
| Amgen Inc | US0311621009 | 6,10% |
| Gilead Sciences Inc | US3755581036 | 5,97% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 4,90% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 4,72% |
| BioNTech SE ADR | US09075V1026 | 3,03% |
| BeiGene Ltd ADR | US07725L1026 | 2,84% |
| Insmed Inc | US4576693075 | 2,64% |
| Ascendis Pharma AS ADR | US04351P1012 | 2,60% |
| Biomarin Pharmaceutical Inc | US09061G1013 | 2,54% |
| Sonstige | 57,75% |